Evolution of Blood Safety in Switzerland over the Last 25 Years for HIV, HCV, HBV and <i>Treponema pallidum</i>
During the last few decades, efforts to increase the safety of blood and blood products have mainly focused on preventing the viral infections HCV, HIV, HBV and <i>Treponema pallidum</i>. The evolution of these approaches and the achieved increase in safety is shown for the last 25 years...
Main Authors: | Christoph Niederhauser, Caroline Tinguely, Martin Stolz, Michael Vock, Soraya Amar El Dusouqui, Peter Gowland |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/12/2611 |
Similar Items
-
Analysis of Ct value of HBV nucleic acid detection in different blood donors
by: Jingwen CHEN, et al.
Published: (2023-10-01) -
Insights on 21 Years of HBV Surveillance in Blood Donors in France
by: Pierre Cappy, et al.
Published: (2022-11-01) -
Analysis and evaluation of hepatitis B test results of blood nucleic acid testing under different screening modes
by: Yiqin HU, et al.
Published: (2024-09-01) -
Epidemiology of HEV Infection in Blood Donors in Southern Switzerland
by: Stefano Fontana, et al.
Published: (2023-09-01) -
A prospective study to evaluate the clinical specificity of the cobas® MPX test kit for screening for HIV RNA, HCV RNA, and HBV DNA in blood donation samples using the cobas® 6800 system in HBV endemic areas
by: Lei Zhou, et al.
Published: (2025-02-01)